American Journal of Obstetrics & Gynecology
Volume 192, Issue 1 , Pages 121-128, January 2005

Trends and predictors of folic acid awareness and periconceptional use in pregnant women

  • Lolkje T.W. de Jong-van den Berg, PharmD, PhD

      Affiliations

    • Slone Epidemiology Center, Boston University School of Public Health, Boston, Mass
    • Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration, Groningen, The Netherlands
    • Corresponding Author InformationReprint requests: Lolkje T. W. de Jong-van den Berg, PharmD, PhD, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration Guide, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.
    • ,
  • Sonia Hernandez-Diaz, MD, PhD

      Affiliations

    • Slone Epidemiology Center, Boston University School of Public Health, Boston, Mass
    • ,
  • Martha M. Werler, PhD

      Affiliations

    • Slone Epidemiology Center, Boston University School of Public Health, Boston, Mass
    • ,
  • Carol Louik, PhD

      Affiliations

    • Slone Epidemiology Center, Boston University School of Public Health, Boston, Mass
    • ,
  • Allen A. Mitchell, MD

      Affiliations

    • Slone Epidemiology Center, Boston University School of Public Health, Boston, Mass

Received 10 March 2004; received in revised form 20 May 2004; accepted 25 May 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by the National Institute of Child Health and Human Development grant No. HD27697 and the National Heart Lung and Blood Institute grant No. HL50763; the National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, through a grant to the Massachusetts Center for Birth Defects Research and Prevention, Massachusetts Department of Public Health; additional support for the Slone Epidemiology Center Birth Defects Study was provided by Rhone Poulenc Rorer, Aventis, Hoechst Marion Roussel, Pfizer, and the Glaxo-Wellcome Company.

PII: S0002-9378(04)00573-3

doi:10.1016/j.ajog.2004.05.085

American Journal of Obstetrics & Gynecology
Volume 192, Issue 1 , Pages 121-128, January 2005

Article Tools

* Image Usage & Resolution